1-phenyl-2-decanoylamino-3-morpholino-1-propanol and atrial natriuretic factor

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with atrial natriuretic factor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amuzie, C; Avolio, A; Bedja, D; Chatterjee, S; Mishra, S1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and atrial natriuretic factor

ArticleYear
Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
    Biochemical and biophysical research communications, 2015, Sep-11, Volume: 465, Issue:1

    Topics: Animals; Apolipoproteins E; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cholesterol; Diet, High-Fat; Enzyme Inhibitors; Galactosyltransferases; Gene Expression; Glucosyltransferases; Glycosphingolipids; Heart Ventricles; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Morpholines; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation

2015